RCKT insider trades & Congress trades
Rocket Pharmaceuticals, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 7 open-market insider transactions in Rocket Pharmaceuticals, Inc. (RCKT) (0 purchases with code P and 7 sales with code S), the most recent on September 11, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 7 sales by 4 ($432K).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Wilson Martin | General Counsel | Sell | 75,364 | $3.40 | $256K | −0.3% |
| Aug 18, 2026 | Shah Gaurav | CEO | Sell | 2,293 | $3.38 | $8K | −0.0% |
| Aug 18, 2026 | Wilson Martin | General Counsel | Sell | 631 | $3.38 | $2K | −0.0% |
| Aug 13, 2026 | Wilson Martin | General Counsel | Sell | 3,493 | $3.38 | $12K | +0.0% |
| Aug 13, 2026 | Shah Gaurav | CEO | Sell | 2,837 | $3.38 | $10K | +0.0% |
| Aug 11, 2026 | Stevens Christopher James | Chief Operating Officer | Sell | 36,658 | $3.50 | $128K | +0.0% |
| Aug 11, 2026 | Chaudhuri Sarbani | See Remarks | Sell | 4,701 | $3.50 | $16K | +0.0% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.